Literature DB >> 29098306

[Differentiated surgical approach for adenocarcinoma of the gastroesophageal junction].

W Schröder1, R Lambertz2, R van Hillegesberger3, C Bruns2.   

Abstract

For adenocarcinoma of the gastroesophageal junction (GEJ) the classification of Siewert with its three subtypes is well established as a practical approach to surgical treatment. Transthoracic esophagectomy with gastric tube formation is generally accepted as the surgical standard for adenocarcinoma of the distal esophagus (GEJ type I). Intrathoracic esophagogastrostomy has become the most frequently used anastomotic technique (Ivor Lewis esophagectomy). Both the abdominal and thoracic part can be safely performed with a minimally invasive access. For subcardiac gastric cancer (GEJ type III) transhiatal extended gastrectomy is the resection of choice. For true cardiac carcinomas (GEJ type II) it has not yet been decided which of the abovementioned surgical procedures offers the best long-term survival. If technically possible in terms of a complete resection, transhiatal extended gastrectomy should be preferred because of a better postoperative quality of life. For GEJ type II tumors a minimally invasive approach is not recommended if the extent of resection cannot be safely determined preoperatively.

Entities:  

Keywords:  Cardiac carcinoma; Esophageal carcinoma; Subcardiac gastric cancer; Transhiatal gastrectomy; Transthoracic esophagectomy

Mesh:

Year:  2017        PMID: 29098306     DOI: 10.1007/s00104-017-0544-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  33 in total

1.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

Review 2.  Methods of esophagogastric anastomoses following esophagectomy for cancer: A systematic review.

Authors:  Roger H Kim; Kazuaki Takabe
Journal:  J Surg Oncol       Date:  2010-05-01       Impact factor: 3.454

Review 3.  Ischemic Conditioning of the Stomach in the Prevention of Esophagogastric Anastomotic Leakage After Esophagectomy.

Authors:  Aristotelis Kechagias; Peter S N van Rossum; Jelle P Ruurda; Richard van Hillegersberg
Journal:  Ann Thorac Surg       Date:  2016-02-05       Impact factor: 4.330

4.  Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients.

Authors:  Jeremiah T Martin; Angela Mahan; Joseph B Zwischenberger; Patrick C McGrath; Ching-Wei D Tzeng
Journal:  J Am Coll Surg       Date:  2014-12-29       Impact factor: 6.113

5.  Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Authors:  Salah-Eddin Al-Batran; Ralf D Hofheinz; Claudia Pauligk; Hans-Georg Kopp; Georg Martin Haag; Kim Barbara Luley; Johannes Meiler; Nils Homann; Sylvie Lorenzen; Harald Schmalenberg; Stephan Probst; Michael Koenigsmann; Matthias Egger; Nicole Prasnikar; Karel Caca; Jörg Trojan; Uwe M Martens; Andreas Block; Wolfgang Fischbach; Rolf Mahlberg; Michael Clemens; Gerald Illerhaus; Katja Zirlik; Dirk M Behringer; Wolff Schmiegel; Michael Pohl; Michael Heike; Ulrich Ronellenfitsch; Martin Schuler; Wolf O Bechstein; Alfred Königsrainer; Timo Gaiser; Peter Schirmacher; Wael Hozaeel; Alexander Reichart; Thorsten O Goetze; Mark Sievert; Elke Jäger; Stefan Mönig; Andrea Tannapfel
Journal:  Lancet Oncol       Date:  2016-10-22       Impact factor: 41.316

6.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

7.  Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.

Authors:  Ralf Gertler; Hubert J Stein; Tibor Schuster; Ina-Christine Rondak; Heinz Höfler; Marcus Feith
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

8.  Diaphragmatic hernia after conventional or laparoscopic-assisted transthoracic esophagectomy.

Authors:  Daniel Vallböhmer; Arnulf H Hölscher; Till Herbold; Christian Gutschow; Wolfgang Schröder
Journal:  Ann Thorac Surg       Date:  2007-12       Impact factor: 4.330

9.  Surgical treatment of adenocarcinomas of the gastro-esophageal junction.

Authors:  K Parry; L Haverkamp; R C G Bruijnen; P D Siersema; J P Ruurda; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2014-09-05       Impact factor: 5.344

10.  Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer.

Authors:  P C van der Sluis; J P Ruurda; R J J Verhage; S van der Horst; L Haverkamp; P D Siersema; I H M Borel Rinkes; F J W Ten Kate; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2015-05-29       Impact factor: 5.344

View more
  1 in total

1.  Dorsal Track Control (DTC): A Modified Surgical Technique for Atraumatic Handling of the Distal Esophagus in Esophagojejunostomy.

Authors:  Nadja Lehwald-Tywuschik; Fabian Steinfurth; Feride Kröpil; Andreas Krieg; Hülya Sarikaya; Wolfram Trudo Knoefel; Martin Krüger; Tahar Benhidjeb; Morris Beshay; Jan Schulte Am Esch
Journal:  J Gastric Cancer       Date:  2019-10-23       Impact factor: 3.720

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.